Vera Therapeutics, Inc. (VERA): Price and Financial Metrics
VERA Price/Volume Stats
| Current price | $43.82 | 52-week high | $50.78 |
| Prev. close | $40.38 | 52-week low | $9.68 |
| Day low | $40.45 | Volume | 1,403,800 |
| Day high | $45.27 | Avg. volume | 911,312 |
| 50-day MA | $40.55 | Dividend yield | N/A |
| 200-day MA | $39.43 | Market Cap | 2.40B |
VERA Stock Price Chart Interactive Chart >
Vera Therapeutics, Inc. (VERA) Company Bio
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
VERA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...